Larvol Delta - FDA-Approval-of-the-FirstEver-PROTAC-Vepdegestrant-ARV471-Marks-a-New-Era-in-Targeted-Protein-Degradation

Veppanu (vepdegestrant) - Rigel Pharmaceuticals

http://www.ncbi.nlm.nih.gov/pubmed/42489504

Anil Kumar; Jia Zhou; Qiang Shen; Saghir Ali

Jul 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next